Cas:42883-45-4 2-chloro-1-(1H-indol-3-yl)-2-phenylethanone manufacturer & supplier

Chemical Name:2-chloro-1-(1H-indol-3-yl)-2-phenylethanone

CAS.NO:42883-45-4

Synonyms:2-Chlor-1-indol-3-yl-2-phenyl-aethanon;2-chloro-1-indol-3-yl-2-phenyl-ethanone;2-Chloro-1-(1H-indol-3-yl)-2-phenyl-ethanone

Molecular Formula:C₁₆H₁₂ClNO

Molecular Weight:269.72600

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:463.4ºC at 760 mmHg

Density:1.307g/cm3

Index of Refraction:1.679

PSA:32.86000

Exact Mass:269.06100

LogP:4.33070

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Chlor-1-indol-3-yl-2-phenyl-aethanon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-1-(1H-indol-3-yl)-2-phenyl-ethanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-chloro-1-indol-3-yl-2-phenyl-ethanone Use and application,2-Chloro-1-(1H-indol-3-yl)-2-phenyl-ethanone technical grade,usp/ep/jp grade.

Related News: An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug. 2-chloro-1-(1H-indol-3-yl)-2-phenylethanone manufacturer The FDA has granted so-called accelerated approval in more than 250 instances since 1992, mainly for rare diseases or small patient populations that have had no effective treatments available to them. In these cases, the agency requires that drugmakers conduct additional clinical trials to prove their therapy works, or face withdrawal from the market. 2-chloro-1-(1H-indol-3-yl)-2-phenylethanone supplier An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug. 2-chloro-1-(1H-indol-3-yl)-2-phenylethanone vendor From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity. 2-chloro-1-(1H-indol-3-yl)-2-phenylethanone factory From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.